|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0009247,
umls-concept:C0009429,
umls-concept:C0019682,
umls-concept:C0019699,
umls-concept:C0032659,
umls-concept:C0038952,
umls-concept:C0205082,
umls-concept:C0205174,
umls-concept:C0231221,
umls-concept:C0241315,
umls-concept:C0556895,
umls-concept:C0681698,
umls-concept:C1414461
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1999-4-20
|
|
pubmed:abstractText |
Antiretroviral triple combination therapies have been evaluated in randomized controlled trials and cohort studies. Little is known about their impact on asymptomatic, severely immunosuppressed, HIV-infected individuals in a real world population.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1077-9450
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
20
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
376-81
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10096582-Acquired Immunodeficiency Syndrome,
pubmed-meshheading:10096582-Adolescent,
pubmed-meshheading:10096582-Adult,
pubmed-meshheading:10096582-Aged,
pubmed-meshheading:10096582-Anti-HIV Agents,
pubmed-meshheading:10096582-Drug Therapy, Combination,
pubmed-meshheading:10096582-Humans,
pubmed-meshheading:10096582-Immune Tolerance,
pubmed-meshheading:10096582-Middle Aged,
pubmed-meshheading:10096582-Prospective Studies,
pubmed-meshheading:10096582-Survivors
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Estimating AIDS-free survival in a severely immunosuppressed asymptomatic HIV-infected population in the era of antiretroviral triple combination therapy. Swiss HIV Cohort Study.
|
|
pubmed:affiliation |
Internal Medicine Outpatient Department, University of Basel, Switzerland.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
